2022
DOI: 10.1016/j.biopha.2021.112522
|View full text |Cite
|
Sign up to set email alerts
|

Curcumin, novel application in reversing myocardial fibrosis in the treatment for atrial fibrillation from the perspective of transcriptomics in rat model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 44 publications
0
11
0
Order By: Relevance
“…These agents can modulate a myriad of molecular mechanisms relevant to AF, including intracellular calcium kinetics, pro-inflammatory cytokine profiles, and the PI3K/Akt/eNOS signaling cascade, as well as modify the expression of certain microRNA levels, resulting in reduced incidence and severity of AF in both preclinical and clinical studies [85][86][87][88][89][90][91]. On the other hand, retinoids, such as fenretinide and tretinoin, have less evidence in the context of AF.…”
Section: Discussionmentioning
confidence: 99%
“…These agents can modulate a myriad of molecular mechanisms relevant to AF, including intracellular calcium kinetics, pro-inflammatory cytokine profiles, and the PI3K/Akt/eNOS signaling cascade, as well as modify the expression of certain microRNA levels, resulting in reduced incidence and severity of AF in both preclinical and clinical studies [85][86][87][88][89][90][91]. On the other hand, retinoids, such as fenretinide and tretinoin, have less evidence in the context of AF.…”
Section: Discussionmentioning
confidence: 99%
“…Some of the herbal ingredients identified herein reportedly alleviate tissue fibrosis by modulating the TGF-β/Smad signaling pathway; for example, curcumin has been reported to attenuate pulmonary, hepatic, and renal interstitial fibrosis ( Saidi et al, 2019 ; Wang Z. et al, 2020 ; Kong et al, 2020 ). Moreover, curcumin has been found to be effective for treating cardiovascular diseases, such as heart failure, myocardial infarction, atherosclerosis ( Li H. et al, 2020 ), and and it can significantly inhibit the duration of atrial fibrillation episodes, attenuate cardiac fibrosis ( Yue et al, 2021 ). However, there are fewer studies on curcumin’s anti-fibrotic effects through its action on TGFBR1.…”
Section: Discussionmentioning
confidence: 99%
“…It also acts as a substrate of lipoxygenase and as an inhibitor of cyclo-oxygenase (COX)-1 and COX-2 enzymes, and is also an inducer of hemoxigenase 23 in vascular endothelial cells, 24,25 rheumatoid arthritis, 26 and works against cardiovascular problems. 27,28 Mainly it has been shown to have anticancer efficacy. 29 Curcumin is an immunogenic inducer of cell death and can potentially be used to induce anti-tumour immune responses; 30 through in vivo experiments, it was found that low doses of a curcumin derivative (ST03) are effective against tumour growth with no apparent systemic toxicity.…”
Section: Therapeutic Properties and Bioavailability Of Curcuminmentioning
confidence: 99%
“…Even at high concentrations of superoxides, curcumin can inhibit the activity of these compounds. It also acts as a substrate of lipoxygenase and as an inhibitor of cyclo‐oxygenase (COX)‐1 and COX‐2 enzymes, and is also an inducer of hemoxigenase 23 in vascular endothelial cells, 24,25 rheumatoid arthritis, 26 and works against cardiovascular problems 27,28 . Mainly it has been shown to have anticancer efficacy 29 .…”
Section: Bioactive Compounds With Potential Biological Activity In Admentioning
confidence: 99%